MYELODYSPLASTIC SYNDROME; MDS
1 competing product in clinical development for MYELODYSPLASTIC SYNDROME; MDS.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Humanized anti-CD117 Monoclonal Antibody (JSP191) | Jasper Therapeutics | Phase 1 | UNKNOWN | 25 |